Fingolimod Completed Phase 4 Trials for Disseminated Sclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01585298STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)
NCT01333501Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms